in an attempt to confirm the previously reported response rates with methyl-ccnu , vincristine , 5-fluorouracil , and streptozotocin ( mof-strep ) ( 34 % ) in advanced colorectal cancer , the gastrointestinal tumor study group used the identical treatment schedule in 40 good performance status patients who had received no prior chemotherapy .
C0016360
5-fluorouracil
C0066687
mof-strep